当前位置:Public Access >页面
Chinese/English
A single-center clinical study evaluating the efficacy and safety of autologous renal-derived epithelial cell-generated corneal endothelial-like cells in the treatment of corneal endothelial decompensation

ChiCTR注册号:

Reg No. in ChiCTR:

ChiCTR2500104539

研究题目:

A single-center clinical study evaluating the efficacy and safety of autologous renal-derived epithelial cell-generated corneal endothelial-like cells in the treatment of corneal endothelial decompensation

Study title:

A single-center clinical study evaluating the efficacy and safety of autologous renal-derived epithelial cell-generated corneal endothelial-like cells in the treatment of corneal endothelial decompensation

 注册状况:

 Registration:

True

注册机构:

中国临床试验注册中心

Name of the Registry:

Chinese Clinical Trial Registry

项目负责人:

中国临床试验注册中心

Corresponding person:

Chinese Clinical Trial Registry

电话:

Telephone:

+86 158 5410 7085

电子邮件

Email

lsuxiasusu@163.com

通讯地址:

山东省济南市槐荫区经四路372号

Address:

372 Jingsi Road, Huaiyin District, Jinan City, Shandong Province, China

邮政编码

Postcode

250000

项目负责人所有单位:

山东第一医科大学附属眼科医院

Institution:

Eye Hospital of Shandong First Medical University

批准本研究的伦理委员会名称:

山东省眼科医院伦理委员会

Name of the ethic committee:

Shandong Eye Hospital Ethics Committee

研究疾病:

角膜内皮失代偿

Study Ailment:

Corneal endothelial decompensation

研究所处阶段:

Study phase:

研究类型:

Type of Study:

Therapy Study

研究团队:

Research team:

研究实施地点:

Site of Study:

国家(地区):

中国

省(直辖市):

山东省

市(区县):

济南市

Country/Area:

China

Province:

Shandong

City:

Jinan
单位 山东第一医科大学附属眼科医院
Institution Eye Hospital of Shandong First Medical University

预计起止时间:

Planned Duration:

2025/5/15 0:00:00-2026/5/15 0:00:00